Topic
Lung Cancer
4 stories about Lung Cancer that passed the news check, newest first.
News ·
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer
On April 18, 2024, the FDA approved alectinib (Alecensa, Genentech) as adjuvant treatment following tumor resection.
What's New: Drugs RSS Feed
Launch ·
FDA approves amivantamab-vmjw with carboplatin and pemetrexed for non-small cell lung cancer with EGFR exon 19 deletions or L858R mutations
On September 19, 2024, the FDA approved amivantamab-vmjw (Rybrevant, Janssen Biotech) with carboplatin and pemetrexed.
What's New: Drugs RSS Feed
Policy ·
FDA approves amivantamab-vmjw for EGFR exon 20 insertion-mutated non-small cell lung cancer indications
The FDA approved amivantamab-vmjw (Rybrevant, Janssen Biotech) with carboplatin and pemetrexed.
What's New: Drugs RSS Feed
Launch ·
FDA approves ensartinib for ALK-positive locally advanced or metastatic non-small cell lung cancer
On December 18, 2024, the FDA approved ensartinib (brand name Ensacove, from Xcovery Holdings, Inc.).
What's New: Drugs RSS Feed